Market Brief: Nifty Outlook and Sector Trends The Nifty 50 enters the current trading week on a cautious footing after closing the previous session at **25,471.10**, marking a decline of **1.30%**. The index has transitioned into a consolidation phase following its inability to sustain levels above the **26,000** psychological mark. Investor sentiment has been dampened by a sharp sell-off in the IT sector and higher-than-expected retail inflation data. January inflation was recorded at **2.75%**, the first reading within the **2%–4%** target range in several months, which has reduced the immediate likelihood of interest rate cuts. Key Technical Levels The index is currently navigating a range-bound environment with a slight bearish tilt in the short term. Traders are monitoring the following technical zones: * **Resistance:** Immediate hurdles are positioned at **25,700**, followed by the significant **26,000** mark. A decisive close above this level is required to reopen the path toward **26,250**. * **Support:** Strong downside protection is anticipated at **25,300** and **25,060**. A breach below these levels could signal a deeper correction toward **24,800**. Sector and Stock Highlights While the broader market remains under pressure, stock-specific action continues to offer opportunities. Banking and select pharmaceutical names have shown relative resilience compared to the technology sector. **Bajaj Finance** remains a top pick after gaining **3.09%** to close at approximately **1,024.75**. Despite a reported **6%** dip in quarterly net profit, the stock attracted buying interest as core income remains robust. **Torrent Pharma** has maintained a steady trend, trading near **4,078** with a monthly return of approximately **3.49%**. The company’s focus on high-margin segments continues to support its valuation. **Tata Motors** and the broader auto sector faced some profit booking, with shares trading lower alongside the index. However, analysts maintain a long-term positive view on the passenger vehicle segment as demand remains healthy. **Dr. Reddy’s Laboratories** and **L&T** are being watched for stability, as defensive buying often shifts toward these heavyweights during periods of high volatility. **Pricol** also remains on the radar for mid-cap participants looking for niche industrial plays. Market Sentiment Foreign Institutional Investors (FIIs) have been net sellers, offloading approximately **$4 billion** in equities in the first month of the year. Conversely, Domestic Institutional Investors (DIIs) and consistent SIP inflows, which remain at record highs, are providing a necessary cushion to the market. Market participants are advised to maintain a disciplined approach, focusing on quality stocks that have recently corrected. High volatility is expected to persist as global geopolitical cues and domestic macro data continue to evolve.